Amalgamated Bank Sells 76,406 Shares of Walgreens Boots Alliance, Inc. (NASDAQ:WBA)

Amalgamated Bank reduced its position in shares of Walgreens Boots Alliance, Inc. (NASDAQ:WBA) by 35.1% in the third quarter, according to the company in its most recent filing with the SEC. The institutional investor owned 141,191 shares of the pharmacy operator’s stock after selling 76,406 shares during the quarter. Amalgamated Bank’s holdings in Walgreens Boots Alliance were worth $1,265,000 at the end of the most recent quarter.

Several other large investors have also bought and sold shares of WBA. Redwood Investment Management LLC boosted its holdings in shares of Walgreens Boots Alliance by 0.9% in the first quarter. Redwood Investment Management LLC now owns 99,661 shares of the pharmacy operator’s stock worth $2,162,000 after buying an additional 850 shares during the last quarter. Inlet Private Wealth LLC raised its position in Walgreens Boots Alliance by 1.9% in the second quarter. Inlet Private Wealth LLC now owns 47,820 shares of the pharmacy operator’s stock worth $578,000 after acquiring an additional 900 shares during the period. Capital Investment Counsel Inc boosted its stake in shares of Walgreens Boots Alliance by 6.6% during the 2nd quarter. Capital Investment Counsel Inc now owns 15,340 shares of the pharmacy operator’s stock worth $186,000 after acquiring an additional 950 shares during the last quarter. Continuum Advisory LLC grew its position in shares of Walgreens Boots Alliance by 71.2% during the 2nd quarter. Continuum Advisory LLC now owns 2,453 shares of the pharmacy operator’s stock valued at $30,000 after acquiring an additional 1,020 shares during the period. Finally, Sumitomo Mitsui DS Asset Management Company Ltd increased its stake in shares of Walgreens Boots Alliance by 1.6% in the 2nd quarter. Sumitomo Mitsui DS Asset Management Company Ltd now owns 65,690 shares of the pharmacy operator’s stock worth $795,000 after purchasing an additional 1,038 shares in the last quarter. 58.59% of the stock is owned by hedge funds and other institutional investors.

Walgreens Boots Alliance Stock Performance

NASDAQ:WBA opened at $9.03 on Thursday. The company has a market cap of $7.81 billion, a P/E ratio of -0.90, a P/E/G ratio of 1.18 and a beta of 0.69. Walgreens Boots Alliance, Inc. has a twelve month low of $8.22 and a twelve month high of $27.05. The company’s 50-day moving average price is $9.18 and its 200-day moving average price is $12.01. The company has a current ratio of 0.68, a quick ratio of 0.37 and a debt-to-equity ratio of 0.67.

Walgreens Boots Alliance (NASDAQ:WBA) last issued its earnings results on Tuesday, October 15th. The pharmacy operator reported $0.39 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $0.36 by $0.03. Walgreens Boots Alliance had a positive return on equity of 14.23% and a negative net margin of 5.85%. The business had revenue of $37.50 billion during the quarter, compared to the consensus estimate of $35.75 billion. During the same period last year, the company earned $0.67 EPS. The company’s revenue for the quarter was up 5.9% on a year-over-year basis. On average, sell-side analysts forecast that Walgreens Boots Alliance, Inc. will post 1.53 earnings per share for the current fiscal year.

Walgreens Boots Alliance Dividend Announcement

The business also recently declared a quarterly dividend, which will be paid on Thursday, December 12th. Stockholders of record on Monday, November 18th will be paid a $0.25 dividend. This represents a $1.00 dividend on an annualized basis and a dividend yield of 11.07%. The ex-dividend date is Monday, November 18th. Walgreens Boots Alliance’s dividend payout ratio (DPR) is -9.99%.

Analyst Upgrades and Downgrades

Several research analysts have recently commented on WBA shares. Truist Financial decreased their price objective on Walgreens Boots Alliance from $13.00 to $10.00 and set a “hold” rating on the stock in a research note on Monday, October 7th. UBS Group upped their price target on shares of Walgreens Boots Alliance from $9.00 to $10.00 and gave the stock a “neutral” rating in a research report on Thursday, October 17th. Evercore ISI raised their price objective on shares of Walgreens Boots Alliance from $7.50 to $10.00 and gave the company an “in-line” rating in a research report on Wednesday, October 16th. JPMorgan Chase & Co. dropped their target price on shares of Walgreens Boots Alliance from $20.00 to $15.00 and set an “overweight” rating for the company in a report on Friday, August 30th. Finally, Barclays raised their price target on Walgreens Boots Alliance from $7.00 to $8.00 and gave the company an “underweight” rating in a report on Wednesday, October 16th. Four analysts have rated the stock with a sell rating, nine have issued a hold rating and two have issued a buy rating to the company. According to MarketBeat, the company currently has a consensus rating of “Hold” and a consensus target price of $12.88.

Walgreens Boots Alliance Company Profile

Walgreens Boots Alliance, Inc operates as a healthcare, pharmacy, and retail company in the United States, the United Kingdom, Germany, and internationally. It operates through three segments: U.S. Retail Pharmacy, International, and U.S. Healthcare. The U.S. Retail Pharmacy segment engages in operation of the retail drugstores, health and wellness services, specialty, and home delivery pharmacy services, which offers health and wellness, beauty, personal care and consumables, and general merchandise.